Thrombosis Anticoagulation Program
Anticoagulant use in the Queen Elizabeth II Health Sciences Centre is widespread, spanning both medical and surgical disciplines.
Anticoagulant therapy requires monitoring for optimal effect and is associated with a high frequency of complications. In addition, novel antithrombotic agents are becoming widely available, which increases the cost and complexity of anticoagulant therapy.
As a result, a Thrombosis Anticoagulation Program was designed and developed to assist and facilitate effective anticoagulation therapy at the QEII Health Sciences Centre.
- Enhance efficacy of hospital utilization
- Improve quality of care for patients that are anticoagulated
- Provide education to patients and the medical staff
- Provide safety and clinical effectiveness utilizing a team approach
- Provide a cost benefit over current patient management
- Outpatient treatment of deep vein thrombosis
- Outpatient treatment of pulmonary embolism
- Perioperative management of oral anticoagulation
- Oral Anticoagulant Therapy Management
- Point-of-Care INR monitoring for those with poor venous access
- Early discharge from hospital of patients with thrombosis
- Follow up of patients started on oral anticoagulants while in hospital
- Follow up of patients with suspected deep vein thrombosis
- Provides Information to Health Care Professionals regarding the use of anticoagulants